147 related articles for article (PubMed ID: 6470759)
1. Therapeutic benefits of combination chemotherapy with vincristine, BCNU, and procarbazine on recurrent cystic craniopharyngioma. A case report.
Bremer AM; Nguyen TQ; Balsys R
J Neurooncol; 1984; 2(1):47-51. PubMed ID: 6470759
[TBL] [Abstract][Full Text] [Related]
2. Intraarterial 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and systemic chemotherapy for malignant gliomas: a follow-up study.
West CR; Avellanosa AM; Barua NR; Patel A; Hong CI
Neurosurgery; 1983 Oct; 13(4):420-6. PubMed ID: 6314173
[TBL] [Abstract][Full Text] [Related]
3. Treatment of recurrent esthesioneuroblastoma with combined intra-arterial chemotherapy. A case report.
Watne K; Hager B
J Neurooncol; 1987; 5(1):47-50. PubMed ID: 3598620
[TBL] [Abstract][Full Text] [Related]
4. Complications associated with intra-arterial BCNU administered in combination with vincristine and procarbazine for the treatment of malignant brain tumors.
Bremer AM; Kleriga E; Nguyen TQ; Balsys R; Northup HM; Gonzalez N; Duarte P; Miller RI
J Neurooncol; 1984; 2(2):129-32. PubMed ID: 6481425
[TBL] [Abstract][Full Text] [Related]
5. Combination chemotherapy with carmustine and cisplatin followed by procarbazine, lomustine, and vincristine for adult high-grade astrocytoma.
Liau CT; Wei KC; Tseng CK; Jung SM
Chang Gung Med J; 2005 Jan; 28(1):16-23. PubMed ID: 15804144
[TBL] [Abstract][Full Text] [Related]
6. Procarbazine, lomustine and vincristine for recurrent high-grade glioma.
Parasramka S; Talari G; Rosenfeld M; Guo J; Villano JL
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011773. PubMed ID: 28744879
[TBL] [Abstract][Full Text] [Related]
7. [Acute signs and symptoms of toxicity due to the BOPP regimen (BCNU, vincristine, procarbazine, cisplatin) during treatment of high-grade astrocytoma].
Jeremić B; Grujicić D; Jevremović S; Mijatović Lj
Srp Arh Celok Lek; 1991; 119(9-10):256-8. PubMed ID: 1806994
[TBL] [Abstract][Full Text] [Related]
8. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR
Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
[TBL] [Abstract][Full Text] [Related]
9. Acute toxicity from BOPP (BCNU, vincristine, procarbazine, cisplatinum) chemotherapy for glioblastoma multiforme.
Jeremić B; Barjaktarević Z; Mijatović L; Djurić L
J Chemother; 1990 Feb; 2(1):67-9. PubMed ID: 2159057
[TBL] [Abstract][Full Text] [Related]
10. Hyperfractionated radiation therapy (HFX RT) followed by multiagent chemotherapy (CHT) in patients with malignant glioma: a phase II study.
Jeremic B; Grujicic D; Antunovic V; Djuric L; Stojanovic M; Shibamoto Y
Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1179-85. PubMed ID: 7961028
[TBL] [Abstract][Full Text] [Related]
11. Modified procarbazine, CCNU, and vincristine (PCV 3) combination chemotherapy in the treatment of malignant brain tumors.
Levin VA; Edwards MS; Wright DC; Seager ML; Schimberg TP; Townsend JJ; Wilson CB
Cancer Treat Rep; 1980; 64(2-3):237-44. PubMed ID: 7407756
[TBL] [Abstract][Full Text] [Related]
12. A retrospective study of the value of chemotherapy as adjuvant therapy to surgery and radiotherapy in grade 3 and 4 gliomas.
Gundersen S; Lote K; Watne K
Eur J Cancer; 1998 Sep; 34(10):1565-9. PubMed ID: 9893629
[TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy of recurrent supratentorial malignant gliomas (phase II study)].
Afra D; Sipos L; Vitanovics D
Ideggyogy Sz; 2002 Jan; 55(1-2):38-44. PubMed ID: 12122942
[TBL] [Abstract][Full Text] [Related]
14. Procarbazine, CCNU and vincristine (PCV) combination chemotherapy for brain tumors.
Brufman G; Halpern J; Sulkes A; Catane R; Biran S
Oncology; 1984; 41(4):239-41. PubMed ID: 6462602
[TBL] [Abstract][Full Text] [Related]
15. Treatment of recurrent malignant supratentorial gliomas with the association of procarbazine, thiotepa and vincristine: a phase II study.
Ameri A; Poisson M; Chen QM; Delattre JY
J Neurooncol; 1993 Jul; 17(1):43-6. PubMed ID: 8120571
[TBL] [Abstract][Full Text] [Related]
16. Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report.
Levin VA; Silver P; Hannigan J; Wara WM; Gutin PH; Davis RL; Wilson CB
Int J Radiat Oncol Biol Phys; 1990 Feb; 18(2):321-4. PubMed ID: 2154418
[TBL] [Abstract][Full Text] [Related]
17. Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas.
Levin VA; Wara WM; Davis RL; Vestnys P; Resser KJ; Yatsko K; Nutik S; Gutin PH; Wilson CB
J Neurosurg; 1985 Aug; 63(2):218-23. PubMed ID: 2991486
[TBL] [Abstract][Full Text] [Related]
18. Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study.
Soffietti R; Nobile M; Rudà R; Borgognone M; Costanza A; Laguzzi E; Mutani R
Cancer; 2004 Feb; 100(4):807-13. PubMed ID: 14770438
[TBL] [Abstract][Full Text] [Related]
19. Intracarotid chemotherapy with a combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), cis-diaminedichloroplatinum (cisplatin), and 4'-O-demethyl-1-O-(4,6-O-2-thenylidene-beta-D-glucopyranosyl) epipodophyllotoxin (VM-26) in the treatment of primary and metastatic brain tumors.
Stewart DJ; Grahovac Z; Benoit B; Addison D; Richard MT; Dennery J; Hugenholtz H; Russell N; Peterson E; Maroun JA
Neurosurgery; 1984 Dec; 15(6):828-33. PubMed ID: 6392925
[TBL] [Abstract][Full Text] [Related]
20. PCV chemotherapy for recurrent glioblastoma.
Schmidt F; Fischer J; Herrlinger U; Dietz K; Dichgans J; Weller M
Neurology; 2006 Feb; 66(4):587-9. PubMed ID: 16505319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]